Filing Analysis
LifeVantage Corp issued an 8-K to announce its financial results for the fourth quarter and full fiscal year ended June 30, 2026. The filing serves as a formal announcement of the earnings release.
📋 Key Facts
- Reporting period: Fourth quarter and full fiscal year ended June 30, 2026.
- Filing date: August 27, 2026.
- The company issued a press release (Exhibit 99.1) containing the financial results.
LifeVantage Corporation announced the Board's approval of a new 2026 New Employee Long-Term Incentive Plan. The plan is designed to attract and retain new employees through equity awards, excluding incentive stock options.
📋 Key Facts
- The Board approved the '2026 New Employee Long-Term Incentive Plan' on July 31, 2026.
- The plan was adopted without stockholder approval pursuant to Nasdaq Listing Rule 5635(c)(4).
- The Company has reserved 1,500,000 shares of common stock for issuance under this new plan.
- Awards are restricted to new employees or those returning after a bona fide period of non-employment as an inducement to join the company.
Lifevantage Corporation announced its financial results for the third fiscal quarter and nine months ended March 31, 2026. The filing serves as a formal notice of the earnings release and includes the full press release as an exhibit.
📋 Key Facts
- Financial results cover the three and nine months ended March 31, 2026.
- The announcement was made via a press release on May 6, 2026.
- The information is furnished under Item 2.02 (Results of Operations and Financial Condition).
- Carl A. Aure, Chief Financial Officer, signed the report.
LifeVantage Corporation announced a leadership transition where CEO Steven R. Fife will retire on April 30, 2026, to be succeeded by Terrence O. Moorehead on August 5, 2026. During the interim period, Board member Michael Beindorff will serve as Interim CEO.
🚩 Red Flags
- Guaranteed cash bonus of $425,000 for the new CEO for FY2027, reducing performance-based incentives for the first year.
- A three-month gap between the outgoing CEO's departure and the new CEO's start date requiring an interim appointment.
📋 Key Facts
- CEO Steven R. Fife's retirement is effective April 30, 2026, with a transition advisory term ending September 11, 2026.
- New CEO Terrence O. Moorehead, former CEO of Nature's Sunshine Products, will receive an annual base salary of $850,000 starting August 5, 2026.
- Moorehead's compensation package includes a guaranteed $425,000 bonus for FY2027 and equity grants totaling approximately $7.5 million in RSUs and PSUs.
- Interim CEO Michael Beindorff will be paid $45,833 per month from May 1, 2026, through August 4, 2026.
- Moorehead brings significant industry experience from Nature's Sunshine and Avon Products.
LifeVantage Corp announced the retirement of its President and CEO, Steven R. Fife, effective April 2026. The filing also includes the release of financial results for the periods ended December 31, 2025.
🚩 Red Flags
- CEO departure creates leadership transition risk, even if characterized as a planned retirement.
📋 Key Facts
- Steven R. Fife is retiring as President and Chief Executive Officer and from the Board of Directors.
- The resignation/retirement is expected to be effective in April 2026.
- The company stated the retirement is not due to any disagreement regarding operations, financial policies, or practices.
- Financial results for the three and six months ended December 31, 2025, were released via press release.
LifeVantage Corp announced the upcoming resignations of two key executives: the Chief Marketing Officer and the Chief Information and Innovation Officer. Both departures are scheduled for mid-to-late December 2025.
🚩 Red Flags
- Simultaneous departure of two C-suite officers (CMO and CIIO) within a three-week window may indicate internal instability or shifts in corporate strategy.
📋 Key Facts
- Julie Boyster, Chief Marketing Officer, will resign effective December 12, 2025.
- Todd Thompson, Chief Information and Innovation Officer, will resign effective December 24, 2025.
- Both executives cited the pursuit of other business opportunities as the reason for departure.
LifeVantage Corp held its fiscal year 2026 annual meeting of stockholders on November 6, 2025. The results included the election of seven directors and the ratification of Deloitte & Touche, LLP as independent auditors.
📋 Key Facts
- Annual Meeting held on November 6, 2025.
- Quorum achieved: 9,571,454 shares (75.41% of 12,691,009 outstanding shares).
- Seven director nominees were elected to serve until the fiscal year 2027 annual meeting.
- Deloitte & Touche, LLP was ratified as the independent registered public accounting firm for FY ending June 30, 2026.
- Shareholders approved an advisory resolution on executive compensation (Say-on-Pay).
- Shareholders approved an amendment to the 2017 Long-Term Incentive Plan.
LifeVantage Corp issued an 8-K to announce its financial results for the third quarter ended September 30, 2025. The filing serves as a formal notice of the earnings release via press release.
📋 Key Facts
- Reporting period: Three months ended September 30, 2025
- Filing date: November 4, 2025
- The company released financial results through a press release (Exhibit 99.1)
- Signed by Carl A. Aure, Chief Financial Officer
LifeVantage Corp filed an 8-K to announce its financial results for the fourth quarter and full fiscal year ended June 30, 2025. The filing serves as a formal notice that a press release containing these results was issued on September 4, 2025.
📋 Key Facts
- Reporting period: Fourth quarter and full fiscal year ended June 30, 2025.
- Filing date: September 4, 2025.
- The filing includes a press release as Exhibit 99.1 containing the financial results.
LifeVantage Corp issued an 8-K to announce its financial results for the three and nine months ended March 31, 2025. The filing serves as a formal notification of the release of quarterly earnings data.
📋 Key Facts
- Report date: May 6, 2025
- Reporting period: Three and nine months ended March 31, 2025
- The company released its financial results via press release (Exhibit 99.1)
- Signed by Carl A. Aure, Chief Financial Officer
LifeVantage Corp filed an 8-K to announce its financial results for the three and six months ended December 31, 2024. This is a routine earnings release filing.
📋 Key Facts
- Reporting period: Three and six months ended December 31, 2024.
- Filing date: February 5, 2025.
- The company issued a press release (Exhibit 99.1) containing the financial results.
LifeVantage Corp has eliminated its Series A Junior Participating Preferred Stock following the expiration of a Rights Agreement. This action effectively terminates the rights previously granted to common stockholders to purchase these preferred shares.
📋 Key Facts
- The Rights Agreement dated August 30, 2023, expired effective August 28, 2024.
- The Company filed a Certificate of Elimination with the Secretary of State of Delaware on November 18, 2024.
- No shares of Series A Preferred Stock were issued or outstanding at the time of elimination.
- The eliminated shares will be returned to the authorized but undesignated pool of preferred stock.
LifeVantage Corp held its fiscal year 2025 annual meeting of stockholders on November 7, 2024. The filing reports the final voting results for director elections, executive compensation advisory votes, auditor ratification, and amendments to incentive plans.
📋 Key Facts
- Annual Meeting held on November 7, 2024.
- Quorum reached: 8,790,929 shares (70.4% of outstanding common stock) were represented.
- All eight director nominees were elected to serve until the fiscal year 2026 annual meeting.
- Deloitte & Touche, LLP was ratified as the independent registered public accounting firm for FY ending June 30, 2025.
- Stockholders approved amendments to both the 2017 Long-Term Incentive Plan and the 2019 Employee Stock Purchase Plan.
- Advisory vote on executive compensation frequency resulted in a preference for 'Every Year'.
Lifevantage Corp issued an 8-K to announce its financial results for the three months ended September 30, 2024. The filing serves as a formal notice that a press release containing these results has been issued.
📋 Key Facts
- Reporting period: Three months ended September 30, 2024.
- Filing date: October 29, 2024.
- The filing includes Exhibit 99.1, which is the official press release regarding financial results.
LifeVantage Corp announced its financial results for the fourth quarter and full fiscal year ended June 30, 2024. The filing serves as a formal announcement of the earnings release issued on August 28, 2024.
📋 Key Facts
- Reporting period: Fourth quarter and full fiscal year ended June 30, 2024.
- Filing date: August 28, 2024.
- The filing includes the announcement of financial results via press release (Exhibit 99.1).
LifeVantage Corp announced the resignation of Board member Erin Brockovich and the simultaneous appointment of Rajendran Anbalagan to the Board and Nominating and Corporate Governance Committee.
🚩 Red Flags
- None identified in this filing.
📋 Key Facts
- Erin Brockovich resigned from the Board effective August 26, 2024; the company stated the resignation was not due to any disagreement regarding operations, policies, or practices.
- Rajendran Anbalagan appointed to the Board and Nominating and Corporate Governance Committee effective August 26, 2024.
- Mr. Anbalagan has been deemed an independent director under Nasdaq and SEC standards.
- Compensation for Mr. Anbalagan includes a restricted stock award valued at $105,000 based on the average closing price of the ten trading days preceding the grant.
LifeVantage Corp issued an 8-K to announce its financial results for the three and nine months ended March 31, 2024. The filing serves as a formal notification of the release of quarterly earnings data.
📋 Key Facts
- Report date: May 2, 2024
- Reporting period: Three and nine months ended March 31, 2024
- The company issued a press release (Exhibit 99.1) containing the financial results.
- Signed by Carl A. Aure, Chief Financial Officer.
LifeVantage Corp entered into a $5,000,000 revolving line of credit agreement with Bank of America, N.A. on April 12, 2024. The facility is secured by substantially all assets of the Company and its guarantor, Lifeline Nutraceuticals Corporation.
🚩 Red Flags
- The loan is secured by 'substantially all of the assets' of both the Company and the Guarantor, indicating high lender priority over company assets.
- Contains customary restrictive covenants that limit the ability to incur additional debt or acquire other companies.
- Default interest rate increases by 2.00% upon occurrence of default.
📋 Key Facts
- Entered into a Loan Agreement with Bank of America, N.A. on April 12, 2024.
- Revolving line of credit amount: up to $5,000,000.
- Interest rate: Term SOFR + 2.00% (or minimum 2.00% per annum).
- Maturity/Expiration Date: April 12, 2027.
- Security: Substantially all assets of LifeVantage Corp and Lifeline Nutraceuticals Corporation are pledged as collateral.
- Guarantor: Lifeline Nutraceuticals Corporation provides a continuing and unconditional guaranty.
LifeVantage Corp entered into a Cooperation Agreement with the 'Radoff' and 'Sudbury' parties to resolve a Section 220 books and records demand. The agreement includes board expansion, director appointments, and significant restrictions on stockholder nominations and voting for several years.
🚩 Red Flags
- Settlement of a Section 220 books and records demand often indicates significant shareholder activism or internal disputes regarding corporate governance.
- The agreement imposes heavy restrictions on the ability of shareholders to nominate directors for several years (through 2027), which can be viewed as defensive management tactics.
📋 Key Facts
- Effective Date: February 14, 2024.
- The Company increased the Board size by one seat to appoint Dayton Judd to the Board, Audit Committee, and Nominating/Corporate Governance Committee.
- Stockholder Parties irrevocably withdrew their Section 220 demand to inspect books and records.
- Agreement includes a multi-year 'staggered' nomination restriction: Incumbent directors are protected from new nominations through the 2025, 2026, and 2027 annual meetings under specific conditions.
- Stockholder Parties agreed to vote their shares in favor of Board recommendations subject to certain exceptions.
- The agreement includes mutual releases of claims and non-disparagement clauses.
- Termination Date: The earlier of 30 days prior to the 2027 nomination window or 120 days before the first anniversary of the 2026 Annual Meeting.
LifeVantage Corp issued an 8-K to announce its financial results for the three and six months ended December 31, 2023. The filing serves as a formal notification that a press release containing these earnings figures has been released.
📋 Key Facts
- Reporting period: Three and six months ended December 31, 2023.
- Filing date: January 30, 2024.
- The filing includes a press release (Exhibit 99.1) detailing results of operations and financial condition.